Cargando…
Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities
Traumatic brain injury (TBI) remains a major cause of death and disability worldwide. Increasing evidence indicates that TBI is an important risk factor for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and chronic traumatic encephalopathy. Despite improved...
Autores principales: | Xiong, Ye, Mahmood, Asim, Chopp, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034172/ https://www.ncbi.nlm.nih.gov/pubmed/29764704 http://dx.doi.org/10.1016/j.cjtee.2018.02.003 |
Ejemplares similares
-
Potential immunotherapies for traumatic brain and spinal cord injury
por: Putatunda, Raj, et al.
Publicado: (2018) -
Analysis of incidence of traumatic brain injury in blunt trauma patients with Glasgow Coma Scale of 12 or less
por: Becker, Alexander, et al.
Publicado: (2018) -
Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018) -
Dangers from Ligature of Main Arteries
Publicado: (1918) -
Emerging potential of exosomes for treatment of traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2017)